Advertisement

Topics

Pulse Biosciences Submits 510(k) Application to FDA for PulseTx™ System

08:30 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), today announced the submission of a 510(k) to the US Food...

Other Sources for this Article

Investors:
Pulse Biosciences, Inc.
Darrin Uecker
President and Chief Executive Officer
IR@pulsebiosciences.com
or
Media:
Sam Brown, Inc.
Hannah Hurdle, 805-601-5331
hannahhurdle@sambrown.com

NEXT ARTICLE

More From BioPortfolio on "Pulse Biosciences Submits 510(k) Application to FDA for PulseTx™ System"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...